Yahoo News: Cancer

Initial prostate biopsies may be more accurate at academic centers

Thu, 01/15/2015 - 17:07
By Lisa Rapaport Men may get more accurate prostate cancer biopsies at an academic medical center than at a community hospital, say Canadian researchers. If the tumors do turn more risky, they’re reclassified, and researchers found that tumors biopsied at non-academic facilities, such as community hospitals, were much more likely to be reclassified than those taken at a major medical center ...

Cancer-stricken Iranian teacher's pupils shave heads

Wed, 01/14/2015 - 17:40
It is a disease that strikes tens of thousands of Iranians each year, but for 300 pupils news that their teacher had cancer prompted an unusual response -- they shaved their heads in sympathy. "They did it out of respect to a teacher and a champion," Abdollah Jafari, an education official in Hamedan province who witnessed the pupils' en-masse gesture after morning classes on Wednesday, told Mehr ...

Colorado group helps breast cancer survivors get tattoos

Wed, 01/14/2015 - 13:22
For women who have survived breast cancer, breast or nipple reconstruction can be a first step toward looking like their old selves. A Colorado organization is helping some of those women, and others who ...

Colorado group helps breast cancer survivors get tattoos

Wed, 01/14/2015 - 06:32
WEST ALLIS, Wis. (AP) — For women who have survived breast cancer, breast or nipple reconstruction can be a first step toward looking like their old selves. A Colorado organization is helping some of those women, and others who don't choose reconstruction, in their emotional healing — through tattoos to help conceal their scars.

Racial differences in breast cancer outcomes are partly biological

Tue, 01/13/2015 - 22:49
By Andrew M. Seaman (Reuters Health) – Some of the differences in breast cancer outcomes between white and black women in the U.S. can be attributed to biology, suggests a new study. Compared to black women, non-Hispanic white women were more likely to be diagnosed when their breast cancer was at an early stage, the research showed. And black women had a higher risk of dying from their breast ...

Express Scripts sees opportunity to lower cancer treatment cost

Tue, 01/13/2015 - 21:29
By Susan Kelly and Bill Berkrot (Reuters) - Express Scripts, the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in the decision-making process. Express Scripts, which has become more aggressive in negotiating discounts on drugs for insurance plans and employers, in December stopped covering ...

Terminal cancer patient dies amid medical marijuana fight

Tue, 01/13/2015 - 18:18
DAVENPORT, Iowa (AP) — An eastern Iowa man has died of cancer just months after he was convicted for growing medicinal marijuana for personal use.

Mastectomy vs. Lumpectomy for Early Breast Cancer: How to Choose

Tue, 01/13/2015 - 15:48
Each year more than 200,000 women diagnosed with early-stage breast cancer, the most common kind, must make myriad treatment decisions. Among them: whether to have a mastectomy or breast-conserving surgery known as a lumpectomy.

Lilly to test combinations with Merck, Bristol-Myers' cancer drugs

Tue, 01/13/2015 - 14:05
(Reuters) - Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong to a promising new class of drugs. Lilly will test its treatments - approved and experimental - in combination with PD-1 inhibitors Keytruda and Opdivo. The treatments are designed to help the body's ...

Cancer survivors plagued by lack of personal control

Tue, 01/13/2015 - 00:24
By Andrew M. Seaman (Reuters Health) – After treatment for cancer, survivors often complain about a loss of personal control, a new study found. The study’s lead author said that while the responses can’t be generalized to all cancer survivors, people in the study often mentioned a physical problem or a wish to return to “normal.” “Cancer survivors are often caught off guard about the lingering ...

Merck, Bristol heat up immunotherapy race in lung cancer

Mon, 01/12/2015 - 20:36
By Bill Berkrot (Reuters) - Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new generation of immune system therapies, adding pressure on the likes of Roche and AstraZeneca to play catch-up. Merck said it would file an application with U.S. regulators in the middle of this year seeking expanded use of its new Keytruda treatment ...

Britain's health service to halt access to some costly cancer drugs

Mon, 01/12/2015 - 17:29
LONDON (Reuters) - Several expensive cancer medicines will no longer be available on Britain's state-funded National Health Service (NHS) following an overhaul of an over-budget drug funding scheme, NHS England said on Monday. The revamp was triggered by the escalating cost of supplying modern cancer therapies, which often cost tens of thousands of pounds for a course of treatment. Drug ...

Britain's health service to halt access to some costly cancer drugs

Mon, 01/12/2015 - 17:28
LONDON (Reuters) - Several expensive cancer medicines will no longer be available on Britain's state-funded National Health Service (NHS) following an overhaul of an over-budget drug funding scheme, NHS England said on Monday. The revamp was triggered by the escalating cost of supplying modern cancer therapies, which often cost tens of thousands of pounds for a course of treatment. Drug ...

Bristol-Myers' stock jumps on lung-cancer drug success

Mon, 01/12/2015 - 16:05
Better patient survival rates prompted Bristol-Myers Squibb to bring an early end to an advanced study of a potential treatment for one of the most common forms of lung cancer. Shares of the New York drugmaker ...

Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts

Mon, 01/12/2015 - 12:40
ZURICH/LOS ANGELES (Reuters) - Roche Holding will acquire a majority stake in molecular and genomic analysis business Foundation Medicine, it said on Monday, signaling its determination to expand in cancer immunotherapy by paying a hefty mark-up on the U.S. company's current price. The deal will help the world's largest maker of cancer drugs push ahead in developing treatments that help the body ...

Merck speeds up drug-submission plans for Hep C, lung cancer: WSJ

Mon, 01/12/2015 - 06:51
(Reuters) - Merck & Co has put on fast track its plans to submit new drugs for hepatitis C and lung cancer for regulatory approval, in an attempt to close the gap with competitors in two lucrative segments, the Wall Street Journal reported. The drugmaker will file an application midyear for U.S. regulatory approval to expand the use of its new cancer immunotherapy Keytruda to include the ...

Bristol-Myers says panel finds Opdivo lung cancer study meets endpoint

Mon, 01/12/2015 - 03:36
(Reuters) - Bristol-Myers Squibb Co said the independent data monitoring committee concluded that a late stage study evaluating Opdivo versus docetaxel in previously treated patients with advanced, squamous cell non-small cell lung cancer met its endpoint. The company said the data demonstrates superior overall survival in patients receiving Opdivo compared to the control arm, indicating a ...

Conn. Supreme Court Rules 17-Year-Old Cancer Patient Must Have Chemo

Fri, 01/09/2015 - 04:13
The top court in Connecticut ruled today that a 17-year-old girl can be forced to undergo chemotherapy after she refused treatment for her cancer.The case went to the Connecticut Supreme court to determine whether the teen, identified in court papers as Cassandra, has "the fundamental right to have a say about what goes on with your [her] body," attorney Michael Taylor, who represents the teen's ...

Docs suggest HPV screening first for cervical cancer

Thu, 01/08/2015 - 22:14
By Andrew M. Seaman (Reuters Health) - Two medical organizations have recommended testing for the human papillomavirus (HPV) to screen women for cervical cancer before using a Papanicolaou – or Pap – smear for screening. The new guidance is not universally accepted by all major medical organizations. However, the document does give some direction to doctors who may use the HPV test for screening ...

Analysts: Pfizer's new type of cancer drug may get OK early

Thu, 01/08/2015 - 20:33
The first in a new class of cancer medicines, Pfizer's Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe. ...

Pages